Brad Daniel

Brad Daniel is an experienced professional in market development and account management, currently serving as the Market Development Manager at MicroGenDX since January 2023, where responsibilities include assisting clinicians in identifying challenging infections through DNA analysis and promoting the clinical benefits of Next Generation Sequencing in various healthcare settings. Prior to this role, Brad held several key positions including VP of Long Term Care and Corporate Development at AIM Laboratories, Senior Account Manager at Sun Pharmaceuticals, and Long Term Care Account Manager at Allergan. Brad's career began in project management at Stumpf Development Corp. with a focus on sales and project management. Educationally, Brad holds a Bachelor's degree in Marketing from Lindenwood University.